Largest real-world study evaluates the effectiveness of third “booster” dose of COVID-19 vaccine

By | October 31, 2021
The Clalit Research Institute, in collaboration with researchers from Harvard University, analyzed one of the world’s largest integrated health record databases to examine the effectiveness of the third dose of the Pfizer/BioNTech BNT162B2 vaccine against the Delta variant of SARS-CoV-2.